MARKER THERAPEUTICS, INC. Research and Development Arrangement, Contract to Perform for Others, Compensation Earned
MARKER THERAPEUTICS, INC. (MRKR) reported Research and Development Arrangement, Contract to Perform for Others, Compensation Earned of $13.10 million for the 1-month period ending 2021-08-31, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned · last filed 2026-08-14
- 2021-08-31: Research and Development Arrangement, Contract to Perform for Others, Compensation Earned $13.10M; Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 1 month $13.10M.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 1 month |
|---|---|---|
| 2021-08-31 | $13.10M 10-Q · filed 2024-08-14 | $13.10M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |